Enhance your practice with CME and tools that focus on the management of neurological conditions.
Recognizing the Signs of TK2 Deficiency
Kaitlin Batley, MD
Recognizing TK2d Across the Lifespan: Clinical Clues by Age of Onset
A Closer Look at the Biology Behind MS Progression
Ethan Meltzer, MD
Navigating Emerging Biomarkers in MS Care
Improving MS Diagnosis and Prognosis with Advanced Imaging and Biomarkers
Implementing Cognitive Screening in MS Care
Elizabeth S. Gromisch, PhD
Engineering Safer Antithrombotic Strategies for Secondary Stroke Prevention
C. Michael Gibson, MD, MS
Valeria Caso, MD, PhD
Ashkan Shoamanesh, MD
The New Era of Targeted Therapy for Myasthenia Gravis
Shruti Raja, MD, MHS
Reimagining Alzheimer's Care: The Advent of Subcutaneous Administration of Anti-Amyloid Therapy
R. Scott Turner, MD, PhD
Recurrence as the Rule: BD Symptoms Persist and Cycle
Jose M. Rubio, MD, PhD
Sunny X. Tang, MD
Emerging Perspectives: The Potential Role of Xanomeline Trospium Across the Bipolar Spectrum
Exploring the Potential Role of Emerging Muscarinic Therapies in the Treatment of Bipolar Disorder
Starting With Confidence: A Practical Framework for Amyloid-Targeting Therapy in Early Alzheimer’s Disease
Dani Cabral, MD
The Role of B-Cell Depletion in MS Care
David Hafler, MD, FANA, MSc
Precision Medicine for Myasthenia Gravis
Discharge Planning After Myasthenic Crisis
Qihua Fan, MD
Exploring Genetic Links Between EBV Clearance and MS Risk
Navigating Emerging Treatment Options in MG
Immunologic Phenotyping: The Future of Personalized MG Care
New Therapies, New Strategy: Rethinking MG Inpatient Care
Loading...
We're glad to see you're enjoying Global Neurology Academy… but how about a more personalized experience?
Press cancel to remain on Global Neurology Academy. Press the link below or the continue button to keep going.